Quarterly report pursuant to Section 13 or 15(d)

Schedule of Stock-based Compensation Expense (Details)

v3.24.1.1.u2
Schedule of Stock-based Compensation Expense (Details) - USD ($)
3 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 167,643 $ 341,504
Research and Development Expense [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total 31,121 99,621
General and Administrative Expense [Member]    
Share-Based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]    
Total $ 136,522 $ 241,883